Dr. Jessica Haberer presented the talk, “Does the monitoring of medication packaging tell us what we need to know about TB treatment adherence” on October 11, 2017 at the UNION meeting in Guadalajara, Mexico. It was one of four presentations highlighting the use of technology to support TB medication adherence. In the talk, Dr. Haberer summarizes the need for adherence-informed approaches to TB treatment, particularly as programs move away from directly observed therapy and toward self-administered therapy. She reviews several types of electronic adherence monitors (e.g., evriMED, Wisepill) and 99DOTS (a cell phone-based reporting system), all of which can be linked to data-driven, patient-centered intervention within a public health delivery context. Dr. Haberer discusses the evidence for impact from these approaches, as well as accuracy and acceptability to patients. She also comments on use of these approaches at scale and identifies areas for future research and development.